The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"

India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

There is not a single instance in history of a vaccine that has been discontinued

Bharat Biotech says its vaccine candidate was found to generate \"robust immune responses\", thus preventing infection and disease in primates upon high amounts of exposure to live SARS-CoV-2 virus

The Serum Institute of India first obtained the approval of the DCGI to conduct Phase I, II and III clinical trials of the vaccine in India

Coronavirus myths: Thanks to the potent combination of social media and mischief-makers, there are an endless number of myths floating around on COVID-19

India's Zydus Cadila, Serum Institute and Bharat Biotech are among the global firms working on COVID-19 vaccine

For the moment, the focus in India is largely to screen people entering the country from the airports and ports, mainly from Africa. It is largely on self-reporting by passengers travelling to India, followed by screening.

India becomes a hot market for optional vaccines.